Kimberly Moran, PhD

Senior Vice President and Head, U.S. Rare Diseases at UCB

Appears in 1 story

Stories

FDA approves Zilbrysq autoinjector for daily self-injection in generalized myasthenia gravis

Leads U.S. rare disease commercialization for UCB

Adults with generalized myasthenia gravis can now take their daily Zilbrysq dose with a spring-loaded autoinjector, not just a prefilled syringe. The FDA cleared the device on October 16, after data showed 90% of first-time users completed an injection without any training.

Updated 3 hours ago